Article
New York - With the incidence of skin cancer increasing around 6 percent annually, dermatologists' best weapons against this illness include clinical advances and accurate public information.
Valisure's David Light Shares Insights Into Newly-Published Benzene and BPO Data
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
FDA Approves sNDA for Actinic Keratosis Drug Dosage Expansion
Join Your Dermatology NP/PA Community at the Elevate Derm PA NP Conference